GrantQuick

health · education · HHS-NIH11

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

National Institutes of Health · PA-25-253

758 days left

Deadline

September 7, 2028

GRANTQUICK SUMMARYPlain-English Overview

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional). National Institutes of Health. This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and... Funding amounts not specified.

Who Should Apply

Public And Indian Housing Authorities, Federally Recognized Native American Tribal Governments, Special district governments, State governments, City/township governments (+10 more)

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

  • Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Is...
  • Deadline: 2028-09-07

💡 GrantQuick Tip

Focus your proposal on clear outcomes, alignment with agency priorities, and demonstrate organizational capacity.

Competitiveness: Moderate to high — federal grants are always competitive

What This Grant Funds

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (epidemiologic, biomedical, behavioral, health care delivery or clinical).

Attachments

Who Can Apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Eligible Applicant Types

Public And Indian Housing AuthoritiesFederally Recognized Tribal GovernmentsSpecial District GovernmentsState GovernmentsCity/Township GovernmentsOther (see NOFO for details)County Governments501(c)(3) NonprofitsSmall BusinessesFor-Profit OrganizationsIndependent School DistrictsOther Tribal OrganizationsPrivate Colleges & UniversitiesNonprofits without 501(c)(3)Public Colleges & Universities

Funding Details

Cost Sharing Required?
No
Funding Instrument
grant

Key Dates

Posted: November 12, 2024
Application Deadline: September 7, 2028 (758 days remaining)

Agency Contact

NIH Grants Information grantsinfo@nih.gov

grantsinfo@nih.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov